Position in TLRY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$271,345
-$107,364 QoQ
Shares Held
41,939
0.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $1,320,238,974 across 27 Drug Manufacturers - Specialty & Generic names. TLRY ranks #27 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,701,747 | $437,583,511 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
4,774,841 | $362,171,687 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,816,657 | $145,077,707 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
8,908,506 | $84,808,976 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
4,986,073 | $69,306,414 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
466,977 | $61,519,549 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,825,651 | $60,374,277 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
2,094,270 | $36,628,782 |
All Filings in TLRY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $271,345 | 41,939 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $378,709 | 41,939 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $379,546 | 219,391 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $89,950 | 219,391 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $144,798 | 219,391 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $291,790 | 219,391 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $386,128 | 219,391 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $364,189 | 219,391 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $541,895 | 219,391 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $504,599 | 219,391 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $524,344 | 219,391 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $342,249 | 219,391 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $555,059 | 219,391 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $244,451 | 90,874 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $249,903 | 90,874 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $283,526 | 90,874 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $706,090 | 90,874 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $638,844 | 90,874 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $431,921 | 38,257 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||